Back
Xylem, Inc. 10K Form
Sell
49
XYL
Xylem, Inc.
Last Price:
$140.86
Seasonality Move:
2.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | XYL/Xylem, Inc. Quarterly |
| 2023-10-31 | 10Q | XYL/Xylem, Inc. Quarterly |
| 2023-08-04 | 10Q | XYL/Xylem, Inc. Quarterly |
| 2023-05-04 | 10Q | XYL/Xylem, Inc. Quarterly |
| 2022-11-01 | 10Q | XYL/Xylem, Inc. Quarterly |
| 2022-08-02 | 10Q | XYL/Xylem, Inc. Quarterly |
Receive XYL News And Ratings
See the #1 stock for the next 7 days that we like better than XYL
XYL Financial Statistics
Sales & Book Value
| Annual Sales: | $8.6B |
|---|---|
| Cash Flow: | $281M |
| Price / Cash Flow: | 37.15 |
| Annual Sales: | $46.02 |
| Price / Book: | 3.06 |
Profitability
| EPS (TTM): | 3.88720 |
|---|---|
| Net Income (TTM): | $943M |
| Gross Margin: | $3.2B |
| Return on Equity: | 8.53% |
| Return on Assets: | 5.64% |
Xylem, Inc. Earnings Forecast
Key Xylem, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for XYL is 37.53%.
-
The Selling, General & Administrative Expenses for XYL have been equal to 22.32% of Gross Profit Margin.
-
The Research & Development expenses have been 2.69% of Revenue.
-
The Interest Expense is 8.54% of Operating Income.
-
The Net Earning history of XYL is 10.39% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 9 years.
Xylem, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | XYL |
| CUSIP: | 98419M |
| Website: | xylem.com |
Debt
| Debt-to-Equity Ratio: | 0.19 |
|---|---|
| Current Ratio: | 1.96 |
| Quick Ratio: | 1.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 38.55 |
|---|---|
| Forward P/E Ratio: | 25.37 |
XYL Technical Analysis vs Fundamental Analysis
Sell
49
Xylem, Inc. (XYL)
is a Sell
Is Xylem, Inc. a Buy or a Sell?
-
Xylem, Inc. stock is rated a SellThe current Xylem, Inc. [XYL] share price is $140.89. The Score for XYL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.